PHARMACOKINETIC PROPERTY OF HUMAN INTERFERON AFTER ADMINISTRATION BY DIFFERENT ROUTES : PROMOTION OF INTESTINAL ABSORPTION AND SPECIFIC TRANSFER INTO LYMPHATICS
スポンサーリンク
概要
著者
-
TAKADA Kanji
Department of Pharmacokinetics, Kyoto Pharmaceutical University
-
高塚 龍之
Faculty Of Humanities And Social Sciences Iwate University
-
Yoshikawa H
Department Of Biopharmaceutics Kyoto Pharmaceutical University:exploratory Development Laboratories
-
SATOH YU-ICHIRO
Basic Research Laboratories, Toray Industries, Inc.
-
TAKADA KANJI
Kyoto College of Pharmacy
-
YOSHIKAWA HIROSHI
Kyoto College of Pharmacy
-
MURANISHI SHOZO
Kyoto College of Pharmacy
-
Takada K
Department Of Biopharmaceutics Kyoto Pharmaceutical University:exploratory Development Laboratories
-
Satoh Yu-ichiro
Basic Research Laboratories Toray Industries Inc.
-
Takada K
Kyoto Pharmaceutical Univ. Kyoto Jpn
-
Tatsumi T
Department Of Physics Kyoto University
-
Muranishi Shozo
Department Of Biopharmaceutics Kyoto Pharmaceutical University:exploratory Development Laboratories
関連論文
- Self-Dissolving Micropile Array Chip as Percutaneous Delivery System of Protein Drug
- Pharmacokinetics of Human Immunodeficiency Virus Protease Inhibitor, Nelfinavir, in Poloxamer 407-Induced Hyperlipidemic Model Rats(Biopharmacy)
- Application of Polyglycolized Glycerides in Protection of Amorphous Form of Etoricoxib during Compression
- Utility of Nano-Sized, Water-in-Oil Emulsion as a Sustained Release Formulation of Glycyrrhizin
- Pharmacokinetics of FK-506,a Novel Immunosuppressant, after Intravenous and Oral Administrations to Rats
- Biological and Pharmaceutical Factors Affecting the Absorption and Lymphatic Delivery of Ciclosporin A from Gastrointestinal Tract
- STUDIES ON THE PROMOTING EFFECT OF LIPID-SURFACTANT MIXED MICELLES (MM) ON INTESTINAL ABSORPTION OF COLLOIDAL PARTICLES. DEPENDENCE ON PARTICLE SIZE AND ADMINISTRATION SITE
- POTENTIATION OF ANTITUMOR EFFECT OF BLEOMYCIN BY FUSOGENIC LIPID AS A MEMBRANE MODIFIER
- THE MODE OF ENHANCED ENTERAL ABSORPTION OF MACROMOLECULES BY LIPID-SURFACTANT MIXED MICELLES I
- POTENTIATION OF ANTITUMOR EFFECT OF BLEOMYCIN BY FUSOGENIC LIPID-SURFACTANT MIXED MICELLES
- ENHANCING EFFECT OF ABSORPTION PROMOTERS ON PERCUTANEOUS ABSORPTION OF A MODEL DYE (6-CARBOXYFLUORESCEIN) AS A POORLY ABBSORBABLE DRUG. III.^ HISTOLOGICAL STUDY AFTER ADDITION OF VARIOUS ABSORPTION PROMOTERS IN RATS
- EFFECT OF ADMINISTRATION ROUTE ON THE SELECTIVE LYMPHATIC DELIVERY OF CYCLOSPORIN A BY LIPID-SURFACTANT MIXED MICELLES
- ENHANCING EFFECT OF ABSORPTION PROMOTERS ON PERCUTANEOUS ABSORPTION OF A MODEL DYE (6-CARBOXYFLUORESCEIN) AS POORLY ABSORBABLE DRUGS. II. STUDY ON THE ABSORPTION PROMOTING EFFECT OF AZONE
- ROLE OF THE DISPERSION SYSTEMS CONTAINING FUSOGENIC LIPIDS ON ENHANCED ABSORPTION OF POORLY ABSORBABLE DRUGS FROM THE GASTROINTESTINAL TRACT
- PROMOTION OF THE SELECTIVE LYMPHATIC DELIVERY OF CYCLOSPORIN A BY LIPID-SURFACTANT MIXED MICELLES
- POTENTIATION OF ANTITUMOR EFFECT OF BLEOMYCIN BY LIPID-SURFACTANT MIXED MICELLES I. IN VIVO AND TUMORNEUTRALIZING ACTIVITY AGAINST MOUSE ETHRLICH ASCITES TUMOR AND RAT ASCITES HEPATOMA AH66
- COMPARISON OF DISAPPEARANCE FROM BLOOD AND LYMPHATIC DELIVERY OF HUMAN FIBROBLAST INTERFERON IN RAT BY DIFFERENT ADMINISTRATION ROUTES
- ENHANCING EFFECT OF ABSORPTION PROMOTERS ON PERCUTANEOUS ABSORPTION OF A MODEL DYE (6-CARBOXYFLUORESCEIN) AS POORLY ABSORBABLE DRUGS. I. COMPARISON OF PLASMA LEVELS AFTER ADDITION OF VARIOUS ABSORPTION PROMOTERS IN RAT
- OPTIMAL DOSAGE REGIMEN CALCULATION BASED ON THE REMAINING DRUG CONCENTRATIONS IN PLASMA
- INTESTINAL ABSORPTION OF CARBOXYFLUORESCEIN ENTRAPPED IN LIPOSOMES IN COMPARISON WITH ITS ADMINISTRATION WITH LIPID-SURFACTANT MIXED MICELLES
- A METHOD TO POTENTIATE ENTERAL ABSORPTION OF INTERFERON AND SELECTIVE DELIVERY INTO LYMPHATICS
- MOLECULAR WIGHT DEPENDENCE OF PERMSELECTIVITY TO RAT SMALL INTESTINAL BLOOD-LYMPH BARRIER FOR EXOGENOUS MACROMOLECULES ABSORBED FROM LUMEN
- PHARMACOKINETIC PROPERTY OF HUMAN INTERFERON AFTER ADMINISTRATION BY DIFFERENT ROUTES : PROMOTION OF INTESTINAL ABSORPTION AND SPECIFIC TRANSFER INTO LYMPHATICS
- Hyperon-Mixed Neutron Stars
- 10pSH-7 超新星物質におけるハイペロン混合と YN、YY 相互作用
- Three-Body Force as an "Extra Repulsion" Suggested from Hyperon-Mixed Neutron Stars(Dense QCD Matter,New Frontiers in QCD 2008-Fundamental Problems in Hot and/or Dense Matter-)
- 21pSA-4 中性子星物質におけるハイペロン混在への対称エネルギーの密度依存性の効果(21pSA 高密度天体・核物質,理論核物理領域)
- 23pZG-12 中性子星におけるΣ^-混在のΣ^-N相互作用依存性(理論核物理領域,実験核物理領域合同,ハイパー核・ストレンジネス,理論核物理領域)
- 24aYE-7 ハイペロン混在中性子星に於ける2π交換型3体力の効果,II(24aYE 天体核物理,理論核物理領域)
- 28aSC-3 ハイペロン混在中性子星における2π交換型3体力の効果(28aSC ハイパー核(K中間子その他),理論核物理領域,実験核物理領域合同,理論核物理領域)
- 23aSD-13 ハイペロン混在物質に於ける斥力効果の問題,II(23aSD 実験核物理領域,理論核物理領域合同 ストレンジネス(ハイパー核),実験核物理領域)
- 27pWF-10 ハイペロン混在物質に於ける斥力効果の問題(27pWF 天体核物理(核物質,EOS),理論核物理領域)
- 27pWF-11 ハイペロンの混じった熱い中性子星II(27pWF 天体核物理(核物質,EOS),理論核物理領域)
- Occurrence of Hyperon Superfluidity in Neutron Star Cores
- 27pWG-5 ハイペロンの混じった熱い中性子星(実験核物理,理論核物理合同 天体核物理(中性子星),実験核物理)
- Hyperon Mixing and EOS of Neutron Star Cores(Proceedings of the YITP Workshop on Nuclear Matter under Extreme Conditions)
- 6a-G-10 YN and YY interactions and hyperonic neutron matter
- 21pSA-6 ハイペロン超流動に対する3体力の効果(21pSA 高密度天体・核物質,理論核物理領域)
- 23pZG-13 ハイペロン混在バリオン物質におけるπ凝縮(理論核物理領域,実験核物理領域合同,ハイパー核・ストレンジネス,理論核物理領域)
- Baryonic ^3P_2-Dominant Superfluidity under Combined Pion Condensation with Δ Isobar. II : Properties of Pairing Interaction and Numerical Results(Nuclear Physics)
- Baryonic ^3P_2-Dominant Superfluidity under Combined Pion Condensation with Δ Isobar. I : Formulation(Nuclear Physics)
- Baryonic ^3P_2-Dominant Superfluidity under Combined Pion Condensation with Δ-Mixing
- ハイペロン混在中性子星が提起する問題(バリオン力とバリオン物質,研究会報告)
- 27pWG-4 「バブルフェルミ殼」形成による異種粒子間の対効果(実験核物理,理論核物理合同 天体核物理(中性子星),実験核物理)
- 27aSJ-13 ハイペロンの混じった超新星物質の状態方程式 II(天体核物理学, 理論核物理)
- 27aSJ-12 フェルミ球の異なる粒子間のペアリングと A 超流動(天体核物理学, 理論核物理)
- Baryon Superfluidity and Neutrino Emissivity of Neutron Stars(Nuclear Physics)
- 27pZH-11 ハイペロンの混じった超新星物質の状態方程式(天体核)(理論核物理)
- 27pZH-6 中性子星に於けるΛ-Σ^-ベアリングの効果,II(天体核)(理論核物理)
- 10pSH-8 中性子星に於ける∧-Σ^- ペアリングの効果
- 28pSA-3 ハイペロン混在中性子星に於けるバリオン超流動とニュートリノ放射率
- Superfluidity of Hyperon-Mixed Neutron Stars
- 有限温度のハイペロン超流動(基研2001年度後期研究会「ストレンジネス核物理最前線」,研究会報告)
- 核物質中のΣ^-Σ^- ^1S_0相関(基研2001年度後期研究会「ストレンジネス核物理最前線」,研究会報告)
- Hyperon-Mixed Neutron Star Matter and Neutron Stars(Nuclear Physics)
- 27pWK-1 中性子星の熱的進化とハイペロン超流動
- 27aXC-7 超新星物質におけるハイペロン混合とその効果
- 高密度核物質におけるハイペロン混合と中性子星(ハイペロンの混合とストレンジネス多体系,研究会報告)
- ハイペロン超流動の中性子星モデル依存性 : 現状報告(ハイペロンの混合とストレンジネス多体系,研究会報告)
- Effective YN and YY Interactions and Hyperon-Mixing in Neutron Star Matter : Y≡Λ Case
- 30pSB-3 ハイベロンガ混在相の現実的結果からみた中性子星冷却へのコメント
- 30pSB-2 高密度ハイベロン物質の状態方程式と中性子星
- The Possibility of Hyperon Superfluids in Neutron Star Cores
- 23aTB-8 中性子星モデルとハイペロン超流動
- Quark ALS構造(高密度核物質と中性子星の現象,研究会報告)
- 29a-HH-7 Chiral Bag ModelによるALS構造
- 30p-Y-1 π場を含むクォーク・バッグ模型による核子系の研究
- 31a-W-4 非対称核物質の熱的性質 II
- 非対称核物質の熱的性質(ハドロン物質の諸相と中性子星の熱的進化,研究会報告)
- Evaluation of Gastrointestinal Transit Characteristics of Oral Patch Preparation Using Caffeine as a Model Drug in Human Volunteers
- Pharmaceutical Approach to HIV Protease Inhibitor Atazanavir for Bioavailability Enhancement Based on Solid Dispersion System(Biopharmacy)
- 31a-CL-9 Δを含めたALSモデルとπ^°凝縮
- Preparation and Rectal Absorption of Highly Concentrated Glycyrrhizin Solution(Biopharmacy)
- 13pSE-9 原子核対称エネルギーと中性子星の冷却(13pSE 核物質・中性子星物質・弱い相互作用,理論核物理領域)
- Evaluation of Factors to Decrease Bioavailability of Cyclosporin A in Rats with Gentamicin-Induced Acute Renal Failure (Biopharmacy)
- Effect of Indinavir on the Intestinal Exsorption of Amprenavir, Saquinavir and Nelfinavir after Intravenous Administration in Rats
- Simultaneous determination of glucocorticoids in plasma or urine by high-performance liquid chromatography with precolumn fluorimetric derivatization by 9-anthroyl nitrile
- Evaluation of Factors to Decrease Plasma Concentration of an HIV Protease Inhibitor, Saquinavir in Ethanol-Treated Rats(Biopharmacy)
- Highly sensitive quantification of vancomycin in plasma samples using liquid chromatography-tandem mass spectrometry and oral bioavailability in rats
- Relationship between Excretion Clearance of Rhodamine 123 and P-Glycoprotein (Pgp) Expression Induced by Representative Pgp Inducers(Biopharmacy)
- In Vivo Effects of Cyclosporin A and Ketoconazole on the Pharmacokinetics of Representative Substrates for P-Glycoprotein and Cytochrome P450 (CYP) 3A in Rats(Biopharmacy)
- Effect of Chronic Administration of Ritonavir on Function of Cytochrome P450 3A and P-Glycoprotein in Rats(Biopharmacy)
- CONTRIBUTION OF SH-PROTEINS TO PROMOTIVE TRANSMUCOSAL PERMEATION OF POORLY ABSORBABLE DYE WITH OLEATE IN RAT COLON
- Clinical Pharmacokinetics of Mycophenolate Mofetil in Japanese Renal Transplant Recipients : a Retrospective Cohort Study in a Single Center(Biopharmacy)
- Permeation Enhancement of Ascorbic Acid by Self-Dissolving Micropile Array Tip through Rat Skin
- Self-Dissolving Micropiles for the Percutaneous Absorption of Recombinant Human Growth Hormone in Rats(Biopharmacy)
- Long-Term Pharmacokinetic Efficacy and Safety of Low-Dose Ritonavir as a Booster and Atazanavir Pharmaceutical Formulation Based on Solid Dispersion System in Rats(Biopharmacy)
- Antihyperglycemic Effect of Insulin from Self-Dissolving Micropiles in Dogs
- Effect of Water Intake on Pharmacokinetics of Lansoprazole from Fast Disintegrating Tablet in Human Subjects
- Bioadhesive Delivery of Metformin Using Prosopis Gum with Antidiabetic Potential
- Studies on the Intestinal Absorption of Low Molecular Weight Heparin Using Saturated Fatty Acids and Their Derivatives as an Absorption Enhancer in Rats (Pharmacology)
- Bioequivalence study and evaluation study for absorption from oral cavity of lansoprazole fast disintegrating tablet in healthy subjects
- Effect of pH, Dietary Proteins and Trypsin Inhibitors on the Hydrolytic Rate of Human Granulocyte Colony-Stimulating Factor (G-CSF) by Rat Digestive Enzymes
- Absorption of Oligodeoxynucleotide by Suppository from Rat Rectal Route
- Evaluation of Carbamazepine Pharmacokinetic Profiles in Mice with Kainic Acid-Induced Acute Seizures(Miscellaneous)
- Effect of Glycerol-Induced Acute Renal Failure on the Pharmacokinetics of Lidocaine after Transdermal Application in Rats(Biopharmacy)
- Evaluation of Gastrointestinal Mucoadhesive Patch System (GI-MAPS) Containing Caffeine as a Model Drug in Human Volunteers
- COLON DELIVERY SYSTEM FOR PEPTIDE/PROTEIN DRUGS
- Effects of Diltiazem on Rheological Properties of Human Blood
- 中性子星コアにおけるハイペロン超流動(ハイペロンの混合とストレンジネス多体系,研究会報告)